SC 13G Filing

Company

Kura Oncology, Inc.

Filed

August 21, 2017

Accession Number

0000930413-17-003002

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →